Granisetron Hydrochloride
Product Images NDC 67877-184

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Granisetron Hydrochloride (NDC 67877-184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label 20tablets (Grani Fig1)

ASCEND Granisetron Hydrochloride Tablets, 1 mg is a unit-dose package containing 20 (2x10) tablets used for institutional purposes only. It is not a child-resistant package. This package is for medication containing 1mg of granisetron hydrochloride tablets. The dosage is 2 mg once or 1mg every day, depending on the prescription of a doctor. The tablets can be taken within one hour before chemotherapy or radiation therapy in case of nausea or vomiting. The tablets should be stored at a temperature between 20°C to 25°C. The manufacturer is Ascend Laboratories, and the supplier is Natco Pharma Limited, India.*

FDA Label Image

Blister Art Work 20 Tablets (Grani Fig2)

This is a description of a packaging foil with specific dimensions. The foil has a width of 196mm and the blister has a size of 94 x 64mm. The repeat length is 70mm and artwork size is 196 x 70mm. The date of manufacture or design is mentioned as 24/09/09.*

FDA Label Image

Carton Label 2 Tablets (Grani Fig3)

Granisetron Hydrochloride Tablets are a medication available in a 1mg dosage. The tablets come in a single-dose package that is not child-resistant and should only be used by adults. The available text is partially readable due to errors.*

FDA Label Image

Blister Art Work 2 Tablets (Grani Fig4)

This is information on Granisetron Hydrochloride tablets, with a strength of 1mg (base). The tablets are manufactured by Natco Pharma Limited in India, and are intended to be used by Ascand Laboratories LLC, based in Montvale, NJ. The ML number is listed as 164MNAPSSFIR.*

FDA Label Image

Blister Art Work 2 Tablets (Grani Fig5)

FDA Label Image

Structure (Grani.str)

The given text seems to represent a chemical compound called "granisetron hydrochloride". However, it is missing some important information and context to provide a more detailed and useful description.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.